LIFEVANTAGE CORP

LFVN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $203.2M $199.5M $206.5M $190.3M $214.0M $208.2M $126.2M $38.9M
Cost of Revenue $34.8M $33.5M $33.9M $28.0M $33.2M $31.8M $18.1M $5.9M
Gross Profit $168.4M $166.0M $172.6M $162.3M $180.8M $171.5M $108.1M $33.0M
Gross Margin 82.9% 83.2% 83.6% 85.3% 84.5% 82.4% 85.7% 84.8%
Operating Expenses
Research & Development $1.2M $1.1M $1.0M $2.4M $2.0M $2.9M $1.4M $509.0K
SG&A Expense $59.8M $64.9M $56.1M $57.4M $56.8M $57.7M $28.7M $7.5M
Operating Income $10.3M $4.4M $13.4M $13.9M $19.4M $12.1M $21.5M $3.7M
Operating Margin 5.1% 2.2% 6.5% 7.3% 9.1% 5.8% 17.0% 9.5%
Interest Expense $456.0K $570.0K $3.3M $3.1M $3.2M $3.0K $8.0K $6.0M
Pretax Income $9.5M $2.9M $8.7M $10.7M $16.7M $11.2M $14.7M $-50.7M
Income Tax Expense $3.8M $1.3M $2.6M $3.5M $5.3M $3.5M $2.2M $92.0K
Net Income $5.8M $1.6M $6.1M $7.1M $11.4M $7.6M $12.5M $-50.8M
Net Margin 2.8% 0.8% 3.0% 3.7% 5.3% 3.7% 9.9% -130.5%
EPS (Basic) $0.41 $0.12 $0.44 $0.51 $0.75 $0.07 $0.12 $-0.69
EPS (Diluted) $0.41 $0.11 $0.42 $0.50 $0.71 $0.06 $0.11 $-0.69
Shares Outstanding (Basic) 14.0M 13.9M 13.7M 13.9M 15.1M 112.3M 102.7M 73.2M
Shares Outstanding (Diluted) 14.1M 14.1M 14.5M 14.2M 15.9M 122.9M 118.3M 73.2M
Dividends Per Share
← Newer Page 2 of 2 Older →